AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10688109 — intervention group
Group type: EXPERIMENTAL
Intervention: 82Rb PET
Number of subjects: 210
Study 10688109 — intervention group
Group type: COMPARATOR
Intervention: Dual-isotope SPECT
Number of subjects: 210
Study 9452696 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash based on triclosan
Number of subjects: 43
Study 9452696 — intervention group
Group type: COMPARATOR
Intervention: Mouthwash based on chlorhexidine (positive control)
Number of subjects: 43
Study 9452696 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash based on Zea mays L
Number of subjects: 43
Study 9452696 — intervention group
Group type: COMPARATOR
Intervention: Placebo (negative control)
Number of subjects: 43
Study 8363075 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane at 1.0 MAC
Number of subjects: 24
Study 8363075 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane at 1.0 MAC
Number of subjects: 24
Study 8363075 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane at 1.5 MAC
Number of subjects: 24
Study 8363075 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane at 1.5 MAC
Number of subjects: 24
Study 8363075 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane at 1.25 MAC
Number of subjects: 24
Study 8363075 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane at 1.25 MAC
Number of subjects: 24
Study 3107493 — intervention group
Group type: EXPERIMENTAL
Intervention: Radionuclide angiocardiography
Number of subjects: 36
Study 3107493 — intervention group
Group type: COMPARATOR
Intervention: Ventriculography
Number of subjects: 36
Study 31152308 — intervention group
Group type: EXPERIMENTAL
Intervention: iv methylprednisolone (20 mg b.i.d)
Number of subjects: 122
Study 31152308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 29709383 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning resource (test group)
Number of subjects: 0
Study 29709383 — intervention group
Group type: COMPARATOR
Intervention: traditional didactic lecture (control group)
Number of subjects: 0
Study 28293345 — intervention group
Group type: EXPERIMENTAL
Intervention: Male involvement intervention (MI)
Number of subjects: 462
Study 28293345 — intervention group
Group type: COMPARATOR
Intervention: No male involvement (control group)
Number of subjects: 462
Study 24589291 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored, multi-component implementation intervention including an implementation seminar, website, and email reminders
Number of subjects: 448
Study 24589291 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation seminar
Number of subjects: 448
Study 22340459 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic navigation system guidance (MNS)
Number of subjects: 40
Study 22340459 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (CMT)
Number of subjects: 40
Study 22340459 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MNS and CMT)
Number of subjects: 40
Study 20147680 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led lifestyle intervention group
Number of subjects: 99
Study 20147680 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (control group)
Number of subjects: 99
Study 20147680 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study 18855510 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal depressive symptoms
Number of subjects: 0
Study 18855510 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal depressive symptoms
Number of subjects: 0
Study 18855510 — intervention group
Group type: EXPERIMENTAL
Intervention: Child noncompliance at age 2
Number of subjects: 0
Study 18855510 — intervention group
Group type: EXPERIMENTAL
Intervention: Child internalizing behaviors at age 4
Number of subjects: 0
Study 18855510 — intervention group
Group type: EXPERIMENTAL
Intervention: Child externalizing behaviors at age 4
Number of subjects: 0
Study 14709944 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (discontinued after 9 to 10 weeks of continuous therapy)
Number of subjects: 0
Study 14709944 — intervention group
Group type: COMPARATOR
Intervention: Placebo (continuing treatment)
Number of subjects: 0
Study 11159255 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized montage (Montage I)
Number of subjects: 72
Study 11159255 — intervention group
Group type: EXPERIMENTAL
Intervention: Montage II
Number of subjects: 72
Study 11159255 — intervention group
Group type: EXPERIMENTAL
Intervention: Montage III
Number of subjects: 72
Study 11159255 — intervention group
Group type: EXPERIMENTAL
Intervention: Montage IV
Number of subjects: 72
Study 9270562 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1a (IFN beta-1a)
Number of subjects: 0
Study 9270562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7934135 — intervention group
Group type: EXPERIMENTAL
Intervention: rhEPO 400 U/kg
Number of subjects: 20
Study 7934135 — intervention group
Group type: EXPERIMENTAL
Intervention: rhEPO during extension phase
Number of subjects: 20
Study 7934135 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline erythropoietin level < 50 mU/ml
Number of subjects: 20
Study 3207009 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics plus acute myringotomy (group B)
Number of subjects: 79
Study 3207009 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics (group A)
Number of subjects: 79
Study 3207009 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 79
Study 29957104 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate Juice (PJ)
Number of subjects: 44
Study 29957104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 28817201 — intervention group
Group type: COMPARATOR
Intervention: Biologics for rheumatoid arthritis
Number of subjects: 0
Study 28817201 — intervention group
Group type: COMPARATOR
Intervention: Different doses of biologics
Number of subjects: 0
Study 28817201 — intervention group
Group type: COMPARATOR
Intervention: Continuous measures of ACR subcomponents
Number of subjects: 0
Study 26005963 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (250 mg bid)
Number of subjects: 115
Study 26005963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 23778198 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent cognitive behavioral group intervention (8 weekly sessions + 1 booster session)
Number of subjects: 540
Study 23778198 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 540
Study 21418923 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐bFGF eye drops, four times a day
Number of subjects: 60
Study 21418923 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐bFGF eye-gel, four times a day
Number of subjects: 60
Study 21418923 — intervention group
Group type: COMPARATOR
Intervention: 0.1% sodium hyaluronate eye drops (Control)
Number of subjects: 60
Study 18482663 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow-mediated constriction (L-FMC)
Number of subjects: 196
Study 18482663 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-mediated dilation (FMD)
Number of subjects: 196
Study 16520567 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse with gingival massage toothbrushing for 2 weeks (4 times per day, 3 minutes per session)
Number of subjects: 61
Study 16520567 — intervention group
Group type: COMPARATOR
Intervention: Control group received toothbrushing education on gingival massage toothbrushing without essential oil mouthrinse
Number of subjects: 61
Study 14746674 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention for one year
Number of subjects: 180
Study 14746674 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health education)
Number of subjects: 180
Study 11020033 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized standard heparin (1.000 U/kg)
Number of subjects: 15
Study 11020033 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized LMWH (Enoksaparin, Clexane, 0.8 mg/kg)
Number of subjects: 15
Study 11020033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9244815 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-linolenic acid from borage seed oil (360 mg daily)
Number of subjects: 24
Study 9244815 — intervention group
Group type: COMPARATOR
Intervention: Corn seed oil (placebo)
Number of subjects: 24
Study 9244815 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-linolenic acid from borage seed oil
Number of subjects: 24
Study 1302545 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy + 10% Brucea javanica emulsion
Number of subjects: 68
Study 1302545 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 68
Study 3937220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprecipitate (20-40 donors, n = 6)
Number of subjects: 11
Study 3937220 — intervention group
Group type: COMPARATOR
Intervention: Stored plasma (250-300 ml, n = 5)
Number of subjects: 11
Study 30511096 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-assisted TKA (group S)
Number of subjects: 100
Study 30511096 — intervention group
Group type: COMPARATOR
Intervention: Manually balanced TKA (group M)
Number of subjects: 100
Study 28823411 — intervention group
Group type: EXPERIMENTAL
Intervention: Female concordant visits
Number of subjects: 103
Study 28823411 — intervention group
Group type: EXPERIMENTAL
Intervention: Female physicians
Number of subjects: 103
Study 28823411 — intervention group
Group type: EXPERIMENTAL
Intervention: Male physicians
Number of subjects: 103
Study 28823411 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender concordance
Number of subjects: 103
Study 27829392 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management & Recovery (IMR) program
Number of subjects: 81
Study 27829392 — intervention group
Group type: EXPERIMENTAL
Intervention: IMR Fidelity Scale
Number of subjects: 81
Study 27829392 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainers' education and supervision
Number of subjects: 81
Study 27829392 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropout rate
Number of subjects: 81
Study 27829392 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of IMR program
Number of subjects: 81
Study 24691459 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 92
Study 24691459 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 92
Study 24691459 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam + Fentanyl
Number of subjects: 92
Study 22520143 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 1136
Study 22520143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1136
Study 21413596 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Lymphocyte Count (TLC)
Number of subjects: 1078
Study 21413596 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin
Number of subjects: 1078
Study 17277790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy during MTX administration
Number of subjects: 130
Study 17277790 — intervention group
Group type: COMPARATOR
Intervention: No cryotherapy during MTX administration (Control)
Number of subjects: 130
Study 15204668 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment for co-occurring conditions
Number of subjects: 1016
Study 15204668 — intervention group
Group type: EXPERIMENTAL
Intervention: Training counseling staff to handle psychotic symptoms
Number of subjects: 1016
Study 11593354 — intervention group
Group type: EXPERIMENTAL
Intervention: n-6 polyunsaturated fat (Trial I)
Number of subjects: 71
Study 11593354 — intervention group
Group type: EXPERIMENTAL
Intervention: Monounsaturated fat (Trial II)
Number of subjects: 71
Study 9520072 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of amyloid beta-peptide (Abeta) in Alzheimer's disease patients
Number of subjects: 0
Study 9520072 — intervention group
Group type: COMPARATOR
Intervention: Cerebrospinal fluid (CSF) levels of amyloid beta-peptide (Abeta) in major depression patients
Number of subjects: 0
Study 8036961 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group with mastery criteria and contingent reinforcement for diet, exercise, weight loss, and parenting skills
Number of subjects: 0
Study 8036961 — intervention group
Group type: COMPARATOR
Intervention: Control group with behavior-change strategies and noncontingent reinforcement
Number of subjects: 0
Study 2658042 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 59
Study 2658042 — intervention group
Group type: COMPARATOR
Intervention: Porcine insulin
Number of subjects: 59
Study 31799861 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol with postoperative intravenous Flubiprofen Axetil or analgesia pump
Number of subjects: 55
Study 31799861 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 55
Study 29626176 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive ceftriaxone
Number of subjects: 2550
Study 29626176 — intervention group
Group type: COMPARATOR
Intervention: Standard stroke unit care (control)
Number of subjects: 2550
Study 27861190 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual acid-etched (DAE) implants
Number of subjects: 14
Study 27861190 — intervention group
Group type: COMPARATOR
Intervention: Machined (MA) implants
Number of subjects: 14
Study 25741159 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue selecting therapy stapler (TST)
Number of subjects: 480
Study 25741159 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan hemorrhoidectomy (M‐M)
Number of subjects: 480
Study 24474353 — intervention group
Group type: EXPERIMENTAL
Intervention: CanalBrush for 20 s at 450 rpm
Number of subjects: 44
Study 24474353 — intervention group
Group type: COMPARATOR
Intervention: Control group A (10 mL 17% EDTA and 10 mL 2.5% NaOCl)
Number of subjects: 44
Study 24474353 — intervention group
Group type: COMPARATOR
Intervention: Control group C (CanalBrush and 10 mL NaOCl)
Number of subjects: 44
Study 21036457 — intervention group
Group type: EXPERIMENTAL
Intervention: Video coaching via cellular phones
Number of subjects: 78
Study 21036457 — intervention group
Group type: COMPARATOR
Intervention: Audio-assisted instructions
Number of subjects: 78
Study 18469250 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior diet standardization (D, n = 32)
Number of subjects: 55
Study 18469250 — intervention group
Group type: COMPARATOR
Intervention: No prior diet standardization (ND, n = 23)
Number of subjects: 55
Study 18469250 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior diet standardization (D)
Number of subjects: 55
Study 18469250 — intervention group
Group type: COMPARATOR
Intervention: No prior diet standardization (ND)
Number of subjects: 55
Study 17144556 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity laser
Number of subjects: 0
Study 17144556 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 0
Study 12680517 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 0
Study 12680517 — intervention group
Group type: EXPERIMENTAL
Intervention: Fans
Number of subjects: 0
Study 12680517 — intervention group
Group type: EXPERIMENTAL
Intervention: Four external cooling strategies
Number of subjects: 0
Study 15798126 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity group (7 visits and full set of resources)
Number of subjects: 274
Study 15798126 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity group (1 visit and limited resources)
Number of subjects: 274
Study 10340280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 2016
Study 10340280 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 2016
Study 10340280 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (non-randomised arm)
Number of subjects: 2016
Study 10340280 — intervention group
Group type: COMPARATOR
Intervention: No treatment (non-randomised arm, Control)
Number of subjects: 2016
Study 7867052 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar restriction (test group, n = 12)
Number of subjects: 20
Study 7867052 — intervention group
Group type: COMPARATOR
Intervention: No dietary advice (control group, n = 8)
Number of subjects: 20
Study 1959402 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (5 mg)
Number of subjects: 180
Study 1959402 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol (5 mg)
Number of subjects: 180
Study 6752874 — intervention group
Group type: EXPERIMENTAL
Intervention: pirprofen 800 mg/day
Number of subjects: 40
Study 6752874 — intervention group
Group type: COMPARATOR
Intervention: ketoprofen 300 mg/day
Number of subjects: 40
Study 27884550 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate/high-glycemic-index (HGI) diet
Number of subjects: 162
Study 27884550 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate/low-glycemic-index (LGI) diet
Number of subjects: 162
Study 27884550 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-carbohydrate/high-monounsaturated-fat (LC) diet
Number of subjects: 162
Study 27884550 — intervention group
Group type: COMPARATOR
Intervention: All diets
Number of subjects: 162
Study 25185470 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management (NOM) with serial clinical examination alone
Number of subjects: 1106
Study 25185470 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management (NOM) with abdominal CT scanning
Number of subjects: 1106
Study 25185470 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative management (NOM) overall
Number of subjects: 1106
Study 25185470 — intervention group
Group type: COMPARATOR
Intervention: Immediate laparotomy
Number of subjects: 1106
Study 25185470 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed laparotomy after NOM
Number of subjects: 1106
Study 24022237 — intervention group
Group type: EXPERIMENTAL
Intervention: Active oromucosal nicotine spray (1 or 2 mg)
Number of subjects: 32
Study 24022237 — intervention group
Group type: COMPARATOR
Intervention: Placebo oromucosal nicotine spray
Number of subjects: 32
Study 22707253 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 0
Study 22707253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18563517 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose L-alanyl-L-glutamine dipeptide [0.5 g/(kg day) glutamine]
Number of subjects: 78
Study 18563517 — intervention group
Group type: COMPARATOR
Intervention: Control group with isonitrogeneous, isocaloric, isovolemic nutritional solution
Number of subjects: 78
Study 18563517 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 78
Study 17330781 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired samples collected before treatment and at recurrence of parasitemia.
Number of subjects: 149
Study 17330781 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent infections in Thai and Burmese patients.
Number of subjects: 149
Study 17330781 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent infections in Indian patients.
Number of subjects: 149
Study 15496604 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk-based formula with 72 mg ribonucleotides/L (FN)
Number of subjects: 477
Study 15496604 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk-fed (HMF)
Number of subjects: 477
Study 15496604 — intervention group
Group type: COMPARATOR
Intervention: Milk-based formula without ribonucleotides (F)
Number of subjects: 477
Study 15496604 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk-based formula with ribonucleotides (FN)
Number of subjects: 477
Study 15496604 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (FN, F, HMF)
Number of subjects: 477
Study 11439411 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week circuit weight training program
Number of subjects: 39
Study 11439411 — intervention group
Group type: COMPARATOR
Intervention: Control group (no weight training)
Number of subjects: 39
Study 9737454 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and Warfarin (WAR)
Number of subjects: 56
Study 9737454 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 56
Study 7520395 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm treated with pentoxifylline and 2-deoxyadenosine
Number of subjects: 0
Study 7520395 — intervention group
Group type: COMPARATOR
Intervention: Control group (sperm not treated with pentoxifylline and 2-deoxyadenosine)
Number of subjects: 0
Study 7520395 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and control groups
Number of subjects: 0
Study 2902545 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry
Number of subjects: 22
Study 2902545 — intervention group
Group type: COMPARATOR
Intervention: Topical beta-blocker treatment
Number of subjects: 22
Study 30611727 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 44
Study 30611727 — intervention group
Group type: COMPARATOR
Intervention: Active Control (AC)
Number of subjects: 44
Study 28685397 — intervention group
Group type: EXPERIMENTAL
Intervention: 3QD regimen (once daily: ombitasvir/paritaprevir/ritonavir and dasabuvir)
Number of subjects: 0
Study 28685397 — intervention group
Group type: COMPARATOR
Intervention: 3‐DAA regimen (twice daily: ombitasvir/paritaprevir/ritonavir and dasabuvir)
Number of subjects: 0
Study 25688779 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (0.5mg/kg per 12 hours for 5 days)
Number of subjects: 120
Study 25688779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 25688779 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 120
Study 22658379 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention (SMART study)
Number of subjects: 113
Study 21330621 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum isometric ankle dorsiflexion contractions (1 second duration)
Number of subjects: 11
Study 21330621 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS data acquisition (subset of 7 subjects)
Number of subjects: 11
Study 20395851 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 660